151 related articles for article (PubMed ID: 33791227)
1. The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma.
Zhang K; Xu C; Liu S; Jiang Y; Zhao X; Ma S; Li Y; Yang F; Wang Y; Meng P; Shi C; Han D; Wen W; Qin W
Front Oncol; 2021; 11():644612. PubMed ID: 33791227
[No Abstract] [Full Text] [Related]
2. CD248
Xu C; Zhang K; Yang F; Zhou X; Liu S; Li Y; Ma S; Zhao X; Lu T; Lu S; Zhang J; Li H; Han D; Wen W; Qin W
Front Oncol; 2021; 11():773063. PubMed ID: 34970489
[TBL] [Abstract][Full Text] [Related]
3. CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma.
Liu S; Xu C; Zhang K; Han D; Yang F; Li Y; Zhao X; Ma S; Li H; Lu S; Lu T; Zhang J; Qin W; Wen W; Yang B
Ann Transl Med; 2021 Dec; 9(23):1741. PubMed ID: 35071435
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder.
Li Y; Zhang K; Yang F; Jiao D; Li M; Zhao X; Xu C; Liu S; Li H; Shi S; Yang B; Yang L; Han D; Wen W; Qin W
Front Oncol; 2021; 11():771036. PubMed ID: 34869004
[TBL] [Abstract][Full Text] [Related]
5. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
Fang X; Liu X; Lu L; Liu G
Front Oncol; 2021; 11():728181. PubMed ID: 34676164
[TBL] [Abstract][Full Text] [Related]
7. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
10. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Lv Y; Duanmu J; Fu X; Li T; Jiang Q
PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
[TBL] [Abstract][Full Text] [Related]
11. Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications.
Zhu G; Pei L; Yin H; Lin F; Li X; Zhu X; He W; Gou X
Oncol Lett; 2019 Nov; 18(5):5235-5242. PubMed ID: 31612034
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Wang Z; Li N; Qi Z; Zhao J; Huang W
Cancer Cell Int; 2021 Jul; 21(1):342. PubMed ID: 34217320
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
14. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
[TBL] [Abstract][Full Text] [Related]
15. Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.
Feng T; Zhao J; Wei D; Guo P; Yang X; Li Q; Fang Z; Wei Z; Li M; Jiang Y; Luo Y
Front Immunol; 2021; 12():762120. PubMed ID: 34712244
[TBL] [Abstract][Full Text] [Related]
16. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
17. Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer.
Xie LY; Huang HY; Hao YL; Yu M; Zhang W; Wei E; Gao C; Wang C; Zeng L
Front Genet; 2023; 14():1067172. PubMed ID: 37007952
[No Abstract] [Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis.
Liu B; Chen X; Zhan Y; Wu B; Pan S
Front Cell Dev Biol; 2020; 8():604627. PubMed ID: 33634098
[No Abstract] [Full Text] [Related]
20. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
